ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,380, issued on Aug. 26, was assigned to GlaxoSmithKline Biologicals SA (Rixensart, Belgium).
"Methods of host cell modification" was invented by Michael Wacker (Unterengstringen, Switzerland), Michael Kowarik (Zurich) and Fabiana Fernandez (Unterengstringen, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods of inserting nucleic acid sequences into host cells. Also described herein are genetically stable host cells comprising inserted nucleic acid sequences and methods of using such host cells in the generation of proteins."
The patent was filed on Dec. 3, 2021, under Application No. 17/541,454.
*For further in...